Acorn Financial Advisory Services’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,748
Closed -$224K 202
2025
Q1
$224K Hold
1,748
0.04% 173
2024
Q4
$231K Sell
1,748
-861
-33% -$121K 0.04% 184
2024
Q3
$380K Hold
2,609
0.07% 134
2024
Q2
$358K Hold
2,609
0.07% 134
2024
Q1
$358K Hold
2,609
0.07% 136
2023
Q4
$355K Hold
2,609
0.06% 182
2023
Q3
$319K Hold
2,609
0.06% 185
2023
Q2
$331K Buy
2,609
+23
+0.9% +$2.99K 0.06% 182
2023
Q1
$334K Hold
2,586
0.07% 167
2022
Q4
$340K Sell
2,586
-390
-13% -$50.4K 0.07% 163
2022
Q3
$347K Sell
2,976
-255
-8% -$31.7K 0.08% 155
2022
Q2
$379K Hold
3,231
0.09% 142
2022
Q1
$421K Hold
3,231
0.08% 149
2021
Q4
$494K Hold
3,231
0.1% 136
2021
Q3
$523K Buy
3,231
+75
+2% +$12.6K 0.16% 129
2021
Q2
$515K Sell
3,156
-396
-11% -$61K 0.15% 144
2021
Q1
$531K Sell
3,552
-53
-1% -$8.42K 0.19% 120
2020
Q4
$545K Hold
3,605
0.21% 120
2020
Q3
$487K Sell
3,605
-123
-3% -$16.7K 0.26% 109
2020
Q2
$508K Sell
3,728
-219
-6% -$27.9K 0.35% 101
2020
Q1
$427K Buy
3,947
+15
+0.4% +$1.73K 0.42% 87
2019
Q4
$474K Buy
+3,932
New +$439K 0.4% 83

Other funds holding IBB

Acorn Financial Advisory Services's IBB Position: Q2 2025 in Review

Acorn Financial Advisory Services sold out of iShares Biotechnology ETF (IBB) in Q2 2025, closing a stake of 1,748 shares — an estimated $224K sold.

Acorn Financial Advisory Services first reported a position in IBB in Q4 2019 and held it in 22 quarters. The position peaked at $545K in Q4 2020. 797 funds tracked by Wall St. Rank hold IBB as of Q2 2025.

  • Acorn Financial Advisory Services reported no remaining iShares Biotechnology ETF position as of Q2 2025 after selling out during the quarter.
  • Acorn Financial Advisory Services sold 1,748 iShares Biotechnology ETF shares in Q2 2025, an estimated $224K.
  • Acorn Financial Advisory Services first reported a position in iShares Biotechnology ETF in Q4 2019 and held it in 22 quarters.
  • Acorn Financial Advisory Services's iShares Biotechnology ETF position peaked at $545K in Q4 2020.
  • 797 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2025.

Based on Acorn Financial Advisory Services's 13F filing for Q2 2025, filed 28 Jul 2025.